Ramalingam SS - Search Results

1

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.

Papadimitrakopoulou VA, Han JY, Ahn MJ, Ramalingam SS, Delmonte A, Hsia TC, Laskin J, Kim SW, He Y, Tsai CM, Hida T, Maemondo M, Kato T, Jenkins S, Patel S, Huang X, Laus G, Markovets A, Thress KS, Wu YL, Mok T. Papadimitrakopoulou VA, et al. Among authors: ramalingam ss. Cancer. 2020 Jan 15;126(2):373-380. doi: 10.1002/cncr.32503. Epub 2019 Nov 26. Cancer. 2020. PMID: 31769875 Free article. Clinical Trial.

2

Recent advances in the treatment of malignant pleural mesothelioma.

Ramalingam SS, Belani CP. Ramalingam SS, et al. J Thorac Oncol. 2008 Sep;3(9):1056-64. doi: 10.1097/JTO.0b013e3181834f66. J Thorac Oncol. 2008. PMID: 18758312 Free article. Review.

3

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.

Belani CP, Schreeder MT, Steis RG, Guidice RA, Marsland TA, Butler EH, Ramalingam SS. Belani CP, et al. Among authors: ramalingam ss. Cancer. 2008 Nov 1;113(9):2512-7. doi: 10.1002/cncr.23902. Cancer. 2008. PMID: 18816622 Free article. Clinical Trial.

4

Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):217-23. doi: 10.1053/j.semtcvs.2008.09.005. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038731 Review.

5

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Pakkala S, Ramalingam SS. Pakkala S, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23. doi: 10.3816/CLC.2009.s.003. Clin Lung Cancer. 2009. PMID: 19362942 Review.

6

Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.

Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, Sun SY. Fan S, et al. Among authors: ramalingam ss. Cancer Biol Ther. 2009 Aug;8(15):1463-9. doi: 10.4161/cbt.8.15.8960. Epub 2009 Aug 8. Cancer Biol Ther. 2009. PMID: 19483468 Free PMC article.

7

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA. Owonikoko TK, et al. Among authors: ramalingam ss. Int J Cancer. 2010 Feb 1;126(3):743-55. doi: 10.1002/ijc.24759. Int J Cancer. 2010. PMID: 19621389 Free PMC article.

8

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

9

Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.

Mok TS, Ramalingam SS. Mok TS, et al. Among authors: ramalingam ss. Cancer. 2009 Nov 15;115(22):5143-54. doi: 10.1002/cncr.24563. Cancer. 2009. PMID: 19658185 Free article. Review.

10

Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.

Ramalingam SS, Belani CP. Ramalingam SS, et al. Curr Opin Oncol. 2010 Mar;22(2):79-85. doi: 10.1097/CCO.0b013e328335a583. Curr Opin Oncol. 2010. PMID: 20009926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters